KR20080073740A - 폐암 진단 검사 - Google Patents

폐암 진단 검사 Download PDF

Info

Publication number
KR20080073740A
KR20080073740A KR1020087013907A KR20087013907A KR20080073740A KR 20080073740 A KR20080073740 A KR 20080073740A KR 1020087013907 A KR1020087013907 A KR 1020087013907A KR 20087013907 A KR20087013907 A KR 20087013907A KR 20080073740 A KR20080073740 A KR 20080073740A
Authority
KR
South Korea
Prior art keywords
markers
lys
lung cancer
ser
glu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087013907A
Other languages
English (en)
Korean (ko)
Inventor
에드워드 에이. 힐스초위즈
리 총
나다 에이치. 카타르
아놀드 제이. 스트롬버그
Original Assignee
유니버시티 오브 캔터키
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 캔터키 filed Critical 유니버시티 오브 캔터키
Publication of KR20080073740A publication Critical patent/KR20080073740A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020087013907A 2005-11-10 2006-11-10 폐암 진단 검사 Withdrawn KR20080073740A (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US73555505P 2005-11-10 2005-11-10
US73541805P 2005-11-10 2005-11-10
US60/735,418 2005-11-10
US60/735,555 2005-11-10
US80677806P 2006-07-08 2006-07-08
US60/806,778 2006-07-08

Publications (1)

Publication Number Publication Date
KR20080073740A true KR20080073740A (ko) 2008-08-11

Family

ID=38228904

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087013907A Withdrawn KR20080073740A (ko) 2005-11-10 2006-11-10 폐암 진단 검사

Country Status (9)

Country Link
US (3) US20090197285A1 (enExample)
EP (1) EP1952157A4 (enExample)
JP (1) JP2009516178A (enExample)
KR (1) KR20080073740A (enExample)
CN (1) CN103245784A (enExample)
AU (1) AU2006332597A1 (enExample)
BR (1) BRPI0619712A2 (enExample)
CA (1) CA2632190A1 (enExample)
WO (1) WO2007079284A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088591B2 (en) * 2006-05-12 2012-01-03 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
KR101018665B1 (ko) 2008-08-18 2011-03-04 재단법인서울대학교산학협력재단 전립선암 진단 방법 및 장치
JP5905003B2 (ja) * 2010-07-09 2016-04-20 ソマロジック・インコーポレーテッド 肺癌バイオマーカーとその使用
KR101857462B1 (ko) 2010-08-13 2018-05-14 소마로직, 인크. 췌장암 바이오마커 및 그것의 용도
WO2012090995A1 (ja) * 2010-12-28 2012-07-05 ライオン株式会社 口腔状態の判定方法、並びにそのために用いられる分析用具、装置、及びプログラム
EP2780714B1 (en) 2011-11-15 2017-08-16 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
WO2016013400A1 (ja) * 2014-07-24 2016-01-28 国立大学法人 長崎大学 肺癌診断用バイオマーカー
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
US11760169B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Particulate control systems and methods for olfaction sensors
US11760170B2 (en) 2020-08-20 2023-09-19 Denso International America, Inc. Olfaction sensor preservation systems and methods
US12377711B2 (en) 2020-08-20 2025-08-05 Denso International America, Inc. Vehicle feature control systems and methods based on smoking
US12251991B2 (en) 2020-08-20 2025-03-18 Denso International America, Inc. Humidity control for olfaction sensors
US12017506B2 (en) 2020-08-20 2024-06-25 Denso International America, Inc. Passenger cabin air control systems and methods
US11881093B2 (en) 2020-08-20 2024-01-23 Denso International America, Inc. Systems and methods for identifying smoking in vehicles
US11636870B2 (en) 2020-08-20 2023-04-25 Denso International America, Inc. Smoking cessation systems and methods
US11813926B2 (en) 2020-08-20 2023-11-14 Denso International America, Inc. Binding agent and olfaction sensor
US11932080B2 (en) 2020-08-20 2024-03-19 Denso International America, Inc. Diagnostic and recirculation control systems and methods
US12269315B2 (en) 2020-08-20 2025-04-08 Denso International America, Inc. Systems and methods for measuring and managing odor brought into rental vehicles
US11828210B2 (en) 2020-08-20 2023-11-28 Denso International America, Inc. Diagnostic systems and methods of vehicles using olfaction
CN116312739A (zh) * 2021-12-20 2023-06-23 博尔诚（北京）科技有限公司 基于甲基化测序的标志物筛选方法、癌症检测方法及装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351824A (en) * 1981-02-05 1982-09-28 Icl Scientific Polystyrene latex reagents, methods of preparation, and use in immunological procedures
AU632469B2 (en) * 1988-04-04 1993-01-07 Johns Hopkins University, The A method for early detection of lung cancer
ES2216295T5 (es) * 1997-06-26 2008-06-01 The Regents Of The University Of Michigan Metodo para la identificacion de antigenos tumorales con autoanticuerpos en suero.
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
WO2001053349A2 (en) * 2000-01-21 2001-07-26 Ludwig Institute For Cancer Research Small cell lung cancer associated antigens and uses therefor
JP2001343389A (ja) * 2000-03-30 2001-12-14 Nippon Kayaku Co Ltd Ｍｄｍ２に対する自己抗体の測定によるがんの検査方法およびその試薬
EP1451587A4 (en) * 2001-11-09 2006-12-06 Benaroya Res Inst At Virginia ANTIGEN PANELS AND METHODS OF USE THEREOF

Also Published As

Publication number Publication date
AU2006332597A1 (en) 2007-07-12
BRPI0619712A2 (pt) 2011-10-11
CN103245784A (zh) 2013-08-14
EP1952157A4 (en) 2009-04-08
US20140066329A1 (en) 2014-03-06
WO2007079284A3 (en) 2008-09-18
CA2632190A1 (en) 2007-07-12
EP1952157A2 (en) 2008-08-06
WO2007079284A2 (en) 2007-07-12
US20120231966A1 (en) 2012-09-13
US20090197285A1 (en) 2009-08-06
JP2009516178A (ja) 2009-04-16

Similar Documents

Publication Publication Date Title
US20120231966A1 (en) Lung cancer diagnostic assay
US20100093108A1 (en) Lung cancer diagnotic assay
Ning et al. Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients
JP5591711B2 (ja) 結腸直腸癌のためのマーカーパネル
CN109142755B (zh) 一种诊断早期食管鳞状细胞癌的四种自身抗体联合检测试剂盒及应用
JP2010509598A (ja) 前立腺癌バイオマーカーを検出するための方法およびキット
Wang et al. Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer
WO2012009382A2 (en) Molecular indicators of bladder cancer prognosis and prediction of treatment response
CN112345755A (zh) 乳腺癌的生物标志物及其应用
CN109187979B (zh) 蛋白芯片、蛋白质芯片诊断试剂盒制备及使用方法
CN113075413B (zh) 基于一组肿瘤相关抗原的早期食管鳞癌筛查试剂盒
KR20110076829A (ko) 암 진단 마커로서의 보체 ｃ９
US10866239B2 (en) Methods for colon hyperproliferative disorder detection, prognosis, and diagnosis
EP2619218B1 (en) Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
MX2008006130A (en) Lung cancer diagnostic assay
CN101374962A (zh) 肺癌的诊断分析法
CN118777605A (zh) 一种用于胰腺癌早期诊断的生物标志物及检验试剂盒
EP2963124B1 (en) Biomarker combinations for use in pancreatic cancer screening
Jia et al. Expressions of VEGF and Chemokines CXCL 13 and CXCL 16 in Malignant Pleural Effusion and Their Clinical Values
GB2541712A (en) Autoantibody biomarkers for gastric cancer
HK1170566B (zh) 分离蛋白-1作为癌症标志物
HK1170566A1 (en) Secernin-1 as a marker for cancer

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080610

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20090129

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid